Target Group, Inc. (Canada) (CBDY)
0.0010
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Target Group Cash from Investing (Quarterly) : -0.0065M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0065M |
| March 31, 2026 | -0.0401M |
| December 31, 2025 | 0.013M |
| September 30, 2025 | 0.0245M |
| June 30, 2025 | 0.0159M |
| March 31, 2025 | 0.028M |
| December 31, 2024 | -0.0501M |
| September 30, 2024 | -0.1427M |
| June 30, 2024 | 0.0164M |
| March 31, 2024 | -0.0025M |
| December 31, 2023 | -0.0181M |
| September 30, 2023 | -0.0105M |
| June 30, 2023 | 0.9844M |
| March 31, 2023 | -0.5389M |
| December 31, 2022 | -0.2251M |
| September 30, 2022 | 0.0502M |
| June 30, 2022 | 1.328M |
| March 31, 2022 | -0.1383M |
| December 31, 2021 | -0.4825M |
| September 30, 2021 | -0.1056M |
| June 30, 2021 | -0.0323M |
| March 31, 2021 | -0.7856M |
| December 31, 2020 | -0.3639M |
| September 30, 2020 | -0.3782M |
| June 30, 2020 | -0.2343M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.1649M |
| September 30, 2019 | 0.6139M |
| June 30, 2019 | -2.262M |
| March 31, 2019 | -1.987M |
| December 31, 2018 | -1.501M |
| September 30, 2018 | -0.3029M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.1376M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -0.0271M |
| InMed Pharmaceuticals, Inc. | 0.00 |
| NervGen Pharma Corp. | -0.0001M |
| Milestone Pharmaceuticals, Inc. | 111.84M |
| Clearmind Medicine, Inc. | -0.6541M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.2229M |
| Cash from Financing (Quarterly) | 0.0309M |
| Free Cash Flow | -1.168M |
| Free Cash Flow Per Share (Quarterly) | -0.0004 |
| Free Cash Flow to Equity (Quarterly) | -0.0065M |
| Free Cash Flow to Firm (Quarterly) | 0.0598M |
| Free Cash Flow Yield | -180.2% |